CIK 0001645113
- Large accelerated filer
NovoCure Ltd
Sign in to watch- Ticker
- NVCR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +44 1534756700
- Business address
- NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
- 4 Grant or award General Counsel acquired 669 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 373 shares (grant or award)
- 4 Grant or award Director acquired 400,412 shares (grant or award)
- 4 Open-market sale Chief Operating Officer sold 44 shares at $16.69 ($734)
- 4 Open-market sale Chief Human Resources Officer sold 810 shares at $15.79 ($12,792)
- 4 Open-market sale EVP, Pres., Novocure Oncology sold 598 shares at $15.94 ($9,531)
- 4 Open-market sale Chief Operating Officer sold 160 shares at $15.88 ($2,540)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award General Counsel acquired 930 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 1,055 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 1,239 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 1,286 shares (grant or award)
- 4 Grant or award EVP, Pres., Novocure Oncology acquired 1,736 shares (grant or award)
- 4 Grant or award Chief Human Resources Officer acquired 1,736 shares (grant or award)
- 4 Open-market sale Chief Financial Officer sold 688 shares at $20.14 ($13,857)
- 4 Exercise or conversion Chief Operating Officer acquired 124,373 shares (option exercise)
- 4 Grant or award Director acquired 4,053 shares (grant or award)
- 4 Grant or award Director acquired 4,053 shares (grant or award)
- 4 Grant or award Director acquired 4,053 shares (grant or award)
- 4 Grant or award Director acquired 4,053 shares (grant or award)
Page 6 of 39 · 780 filings